ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Globenewswire· 2025-06-12 20:25
Recon Supply Named Exclusive U.S. Distributor of ReShape’s STIMEL-03, Lap-Band® 2.0 FLEX, and Full Product Portfolio to Reach U.S. Veterans and Active-Duty Service MembersIRVINE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape’s cutti ...
K Wave Media Announces Upcoming Content Lineup and Expands Bitcoin Strategic Reserve Plan
Globenewswire· 2025-06-12 20:25
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- K Wave Media (Nasdaq: KWM), a global integrated entertainment company, today announced its upcoming slate of film and drama releases for the second half of 2025. Simultaneously, KWM continues executing its Bitcoin (BTC) Strategic Reserve Plan, reinforcing its unique hybrid growth and financial strategy. Strengthening Global Content Pipeline Since its Nasdaq debut on May 14, 2025, KWM has accelerated production across multiple content verticals through its fully in ...
EBC Financial Group 推出 100 多种美国 ETF 差价合约,为全球客户带来更多元化的选择
Globenewswire· 2025-06-12 20:19
全新 ETF 差价合约套件提供全球市场主题、实时访问和灵活性伦敦, June 12, 2025 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC) 宣布推出 100 多种新的美国上市交易所买卖基金 (ETF) 差价合约,扩大其多种资产产品套件,并为全球客户提供更深度的多元化主题式交易机会。 此次新产品面世,彰显 EBC 持续致力于提供跨资产类别的机构级工具,并以灵活性、透明度和效率为基础。 新产品包括在 NYSE (纽约证券交易所) 和 NASDAQ (纳斯达克) 上市的 ETF,由 Vanguard、iShares (BlackRock) 和 State Street Global Advisors 等领先的资产管理公司发行。 主题涵盖广泛的全球宏观形势和行业分类叙事。 EBC Financial Group (UK) Ltd 首席执行官 David Barrett 表示:“此次扩张体现我们将市场相关性融入智能产品设计的愿景。 对于寻求更具战略灵活性的目标敞口的交易者来说,新产品是一种自然的演变。 在 EBC,我们正在建立一个兼顾精确度和效能的生态系统。” 主题式访问 ...
Nasdaq Confirms Full Compliance of HUB Cyber Security with Nasdaq’s Listing Standards
Globenewswire· 2025-06-12 20:19
TEL AVIV, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced secured data fabric technology, today announced that it is in full compliance with all applicable listing requirements of the Nasdaq Capital Market. Nasdaq has formally confirmed that HUB satisfies both the minimum bid price and the market value of listed securities (MVLS) thresholds under Listing Rules 5550(a)(5) and 5550(b)(2), the “Bid ...
Inuvo Reaffirms 25% Q2 YOY Growth Guidance and Completes 1:10 Reverse Stock Split
Globenewswire· 2025-06-12 20:15
LITTLE ROCK, Ark., June 12, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence-driven AdTech solutions, today announced that it was reaffirming its prior guidance that the Company was expecting revenue growth for the second quarter of not less than 25% on a year-over-year basis. The Company also completed a 1-for-10 reverse stock split of its outstanding common stock, as approved by shareholders at the Annual Meeting held on May 22, 2025. Inuvo’s purpos ...
Suominen Corporation – Manager’s transaction: Björnman Tommi
Globenewswire· 2025-06-12 20:15
Suominen Corporation June 12, 2025 at 3:15 p.m. (EEST) Suominen Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Tommi BjörnmanPosition: Chief Executive Officer Issuer: Suominen OyjLEI: 743700Z1BNFYR9PRDF52Notification type: INITIAL NOTIFICATIONReference number: 110660/8/6 ____________________________________________Transaction date: 2025-06-11Outside a trading venueInstrument type: SHAREISIN: FI0009010862Nature of transaction: RECEI ...
ZenaTech's ZenaDrone to File Patent and Accelerate Deployment of Counter-UAS Technology on the ZenaDrone 1000 in Response to US Executive Order
Globenewswire· 2025-06-12 20:15
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces its subsidiary ZenaDrone’s intent to file a patent and accelerate the deployment of Counter-Unmanned Aircraft System (Counter-UAS) technology, to be mounted on the company’s flagship ZenaDrone 1000 drone platform in ...
NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations
Globenewswire· 2025-06-12 20:13
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical industry through streamlined access to actionable analytics uncovered by AI, today announced that NetraMark founder Dr. Joseph Geraci was the lead author on a new publication that outlines the market opportunity for AI/ML to improve data quality and patient outc ...
uSmart Securities Updates Coverage of SAIHEAT Limited
Globenewswire· 2025-06-12 20:00
Reiterates BUY Rating and Raises Price Target to $31.32 Following SMR Breakthrough and Favorable Policy DevelopmentsSINGAPORE, June 12, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW), today announces that uSmart Securities has updated its coverage of the Company, reaffirming its BUY rating on SAIHEAT and raising the 12-month price target to $31.32, up from $25.87. This revision reflects significant advancements in the Company’s nuclear technology, supportive U.S. ...
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Globenewswire· 2025-06-12 20:00
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025 THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation Company initiating a sale process of THB335 SAN FRANCISCO, J ...